Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pain management for sickle cell disease.

R J Dunlop1, K C L B Bennett

  • 1InferMed Ltd, 25 Bedford Square, London, UK, WC1B 3HW. robert.dunlop@infermed.com

The Cochrane Database of Systematic Reviews
|April 21, 2006
PubMed
Summary

Limited evidence exists for managing sickle cell disease pain. Pharmacological interventions show potential for acute pain crises, but more research is needed for effective chronic pain management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is there such a thing as a life not worth living?

BMJ (Clinical research ed.)·2001
Same author

Cytokines and advanced cancer.

Journal of pain and symptom management·2000
Same author

Force output and energy metabolism during neuromuscular electrical stimulation: a 31P-NMR study.

Scandinavian journal of rehabilitation medicine·1997
Same author

Octreotide and the secretory effects of advanced cancer.

Palliative medicine·1996
Same author

On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A reply.

Journal of medical ethics·1995
Same author

Arrhythmias and Guillain-Barre syndrome.

The New Zealand medical journal·1987

Area of Science:

  • Hematology
  • Pharmacology
  • Clinical Pain Management

Background:

  • Sickle cell disease (SCD) is an inherited disorder causing abnormal hemoglobin, leading to red blood cell sickling and severe pain episodes.
  • Current pain management strategies for SCD are often inadequate, impacting patient quality of life.
  • Both acute and chronic pain are significant challenges in SCD management.

Purpose of the Study:

  • To assess the effectiveness of pharmacological analgesic interventions for pain in sickle cell disease.
  • To review treatments for both acute and chronic pain in pediatric and adult SCD patients.
  • To identify gaps in research for SCD pain management.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) from 1965 to 2002.
  • Searches conducted on MEDLINE, EMBASE, CCTR, and Oxford pain RCT database.
  • Included RCTs on pharmacological treatment for acute or chronic pain in SCD patients (HbSS, HbS/β-thalassemia, HbSC).

Main Results:

  • Nine RCTs were identified, all focusing on acute sickle cell pain.
  • Interventions included NSAIDs, strong opioids, and corticosteroids.
  • Limited data, small sample sizes, and methodological heterogeneity hindered meaningful meta-analyses.

Conclusions:

  • No studies addressed chronic pain in sickle cell disease.
  • Limited evidence supports analgesic interventions for acute pain crises; studies are often underpowered.
  • Parenteral corticosteroids may reduce analgesic duration and hospital stay; oral morphine shows comparable efficacy to parenteral for acute pain.

Related Experiment Videos